| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $375,496,085 ) (Continued on the next page) |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01EY035637 | Molecular and cellular requirements for Crb1 gene function in the onset and therapeutic rescue of an inherited retinal degeneration | 000 | 1 | NIH | 1/18/2024 | $565,501 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31EY035168 | Robotic and handheld OCT imaging for diagnosis and treatment of diabetic retinopathy | 003 | 1 | NIH | 5/24/2024 | $0 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31EY035168 | Robotic and handheld OCT imaging for diagnosis and treatment of diabetic retinopathy | 002 | 1 | NIH | 5/10/2024 | $1,280 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31EY035168 | Robotic and handheld OCT imaging for diagnosis and treatment of diabetic retinopathy | 001 | 1 | NIH | 11/30/2023 | $0 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31EY035168 | Robotic and handheld OCT imaging for diagnosis and treatment of diabetic retinopathy | 000 | 1 | NIH | 11/30/2023 | $40,093 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31AI179042 | Investigating the Mucin Utilization Capabilities of Akkermansia muciniphila | 002 | 1 | NIH | 5/8/2024 | $1,280 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | K23HL166022 | The impact of the oral microbiome on pulmonary function among people with HIV in Botswana | 000 | 1 | NIH | 1/8/2024 | $187,835 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31AI179042 | Investigating the Mucin Utilization Capabilities of Akkermansia muciniphila | 000 | 1 | NIH | 1/23/2024 | $47,694 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31AI179042 | Investigating the Mucin Utilization Capabilities of Akkermansia muciniphila | 001 | 1 | NIH | 1/23/2024 | $0 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01CA280970 | Next-generation SMARTs for Discovery and Evaluation of Sequential Cancer Therapeutic Strategies | 000 | 1 | NIH | 12/11/2023 | $369,941 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DK134408 | Dissecting AAV silencing in humanized mice | 001 | 2 | NIH | 5/13/2024 | $36,973 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DK134408 | Dissecting AAV silencing in humanized mice | 000 | 2 | NIH | 1/22/2024 | $554,591 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F99CA284283 | Understanding metabolic and vascular vulnerabilities of residual disease in triple negative breast cancer to inform on treatment strategies | 000 | 1 | NIH | 1/9/2024 | $1,500 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH135932 | DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology | 000 | 1 | NIH | 7/18/2024 | $1,656,252 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01EY035853 | Engineering three-dimensional perfusable microphysiological models of the human inner blood-retina barrier | 000 | 1 | NIH | 12/8/2023 | $664,948 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01HL089221 | Determinants of AAV Tropism | 001 | 14 | NIH | 4/19/2024 | $732,144 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01AI181815 | Membrane repair boosted by caspase signaling | 000 | 1 | NIH | 1/24/2024 | $564,075 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01ES034270 | Which mechanisms of pollutant-induced mitochondrial dysfunction cause dopaminergic neurodegeneration? | 000 | 2 | NIH | 10/19/2023 | $408,316 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01EB017711 | Coherence-Based Fetal Ultrasonic Imaging | 001 | 11 | NIH | 6/7/2024 | $38,218 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01EB017711 | Coherence-Based Fetal Ultrasonic Imaging | 000 | 11 | NIH | 1/22/2024 | $429,966 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DA047301 | Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness | 001 | 5 | NIH | 4/26/2024 | $64,268 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DA047301 | Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness | 000 | 5 | NIH | 12/28/2023 | $578,422 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH129302 | Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis | 003 | 2 | NIH | 7/10/2024 | -$50,357 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH129302 | Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis | 002 | 2 | NIH | 7/5/2024 | $79,078 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01NS112940 | Biomaterials to promote synapse formation after stroke | 001 | 5 | NIH | 4/17/2024 | $35,046 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH129302 | Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis | 001 | 2 | NIH | 3/8/2024 | $64,075 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH129302 | Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis | 000 | 2 | NIH | 11/2/2023 | $711,699 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01NS112940 | Biomaterials to promote synapse formation after stroke | 000 | 5 | NIH | 11/17/2023 | $450,589 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R35GM155282 | Towards the Design of Programmable, Isoform-Selective Proteome Editing System | 000 | 1 | NIH | 7/3/2024 | $402,500 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH102238 | Pathway-Specific Targeting in Subcallosal Cingulate Deep Brain Stimulation for Depression | 001 | 9 | NIH | 7/5/2024 | $51,009 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01MH102238 | Pathway-Specific Targeting in Subcallosal Cingulate Deep Brain Stimulation for Depression | 000 | 9 | NIH | 11/9/2023 | $459,083 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | UM1AI104681 | Antibacterial Resistance Leadership Group (ARLG) | 004 | 12 | NIH | 6/3/2024 | $1,451,944 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | UM1AI104681 | Antibacterial Resistance Leadership Group (ARLG) | 003 | 12 | NIH | 4/23/2024 | $0 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | UM1AI104681 | Antibacterial Resistance Leadership Group (ARLG) | 002 | 12 | NIH | 3/27/2024 | $0 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | UM1AI104681 | Antibacterial Resistance Leadership Group (ARLG) | 001 | 12 | NIH | 12/1/2023 | $13,067,488 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01AI133654 | The Genetic Basis of Virulence in Cryptococcus Neoformans | 001 | 7 | NIH | 5/22/2024 | $57,583 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01AI133654 | The Genetic Basis of Virulence in Cryptococcus Neoformans | 000 | 7 | NIH | 1/23/2024 | $518,250 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R61DA060583 | NOTRE: optimizing long-acting pre-exposure prophylaxis and medications for opioid use disorder interventions in carceral settings | 000 | 1 | NIH | 5/14/2024 | $1,107,431 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01AG069939 | Comprehensive portrait of long-term cannabis users: Are they ready for old age? | 001 | 4 | NIH | 5/13/2024 | $32,294 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01AG069939 | Comprehensive portrait of long-term cannabis users: Are they ready for old age? | 000 | 4 | NIH | 11/9/2023 | $290,646 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01CA256157 | Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC | 001 | 4 | NIH | 4/16/2024 | $32,220 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DK133369 | Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair | 001 | 2 | NIH | 5/6/2024 | $30,260 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01DK133369 | Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair | 000 | 2 | NIH | 1/22/2024 | $453,908 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01NS120417 | Protective role of Clec7a/dectin-1 in CNS autoimmunity | 001 | 4 | NIH | 4/17/2024 | $28,065 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01NR019594 | EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND) | 001 | 4 | NIH | 5/2/2024 | $65,768 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01NR019594 | EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND) | 000 | 4 | NIH | 12/22/2023 | $591,915 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R01HD113543 | Regulation of fertility and reproduction by codon usage: a Drosophila model | 000 | 1 | NIH | 7/23/2024 | $339,402 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | F31HL172589 | Investigating the Effects of Hutchinson-Gilford Progeria Syndrome Mutation Correction in Tissue-Engineered Blood Vessels | 000 | 1 | NIH | 7/22/2024 | $42,132 |
| 2024 | 2024 | DUKE UNIVERSITY | 2200 W MAIN ST | DURHAM | NC | 27705-4640 | DURHAM | USA | R21AG084916 | 'Omics predictors of Sickle Cell Severity and Survival | 000 | 1 | NIH | 7/17/2024 | $430,956 |
|